Carregant...
Haplo is the new black
In this edition of Blood, Bertaina et al report 3-year survival exceeding 90% by using haploidentical αβ(+)CD3(+)/CD19(+)-depleted allogeneic transplantation for children with nonmalignant disorders.(1)
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4118482/ https://ncbi.nlm.nih.gov/pubmed/25082865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-579714 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|